Ocean Biomedical

Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.[1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty.[2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.[3]

Ocean Biomedical
IndustryPharmaceutical
FounderChirinjeev Kathuria
Headquarters
Providence, Rhode Island
,
United States
ProductsMalaria vaccine and others

History

In January 2019[4] Chirinjeev Kathuria co-founded Ocean Biomedical[5] in Rhode Island, United States.[6][7] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time,[8] but currently works as a senior health advisor at Brown.[9] Ocean Biomedical started off as a Brown University biotech "spin-off."[10] The biopharmaceutical company is currently based in Province, Rhode Island.[11] As of 2021 the CEO of the company is Elizabeth Ng.[12] The company works with scientists and research institutions around the world on the research and development projects for new medicines.[13]

In 2021 Ocean Biomedical announced plans to go public[10] and filed for a $100 million IPO.[14]

Areas

Ocean Biomedical has worked in areas such as non-small cell lung cancer[15] and pulmonary fibrosis.[14][16]

Vaccines
Further information: Malaria vaccine

Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19.[17] In 2020, the company announced the discovery of a malaria vaccine.[18][19][20][21][22]

Affiliations and partnerships

Ocean Biomedical also has partnered with scientists such as:[23]

Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster.[12]

References
  1. "Science". Ocean Biomedical. Retrieved July 25, 2023.
  2. "Dr. Jack A. Elias, 25 over Fifty-five". August 23, 2019.
  3. "Approach". Ocean Biomedical. Retrieved July 25, 2023.
  4. "UpHealth, Inc. – Governance – Board of Directors – Person Details". investors.uphealthinc.com.
  5. "chirinjeev-kathuria". ocean biomedical.
  6. "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. Retrieved July 13, 2021.
  7. "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. June 10, 2021. Retrieved June 29, 2021.
  8. Lahmers, Abbie. "Neighborhood News: A space made available to Providence's neighborhood associations free of charge". Providence Media.
  9. "Jack Elias to transition to senior health advisor at Brown, will leave role as medical school dean". Brown University.
  10. "Ocean Biomedical, a Brown University bioscience 'spin-off,' plans to go public – The Boston Globe". BostonGlobe.com.
  11. "Bloomberg". www.bloomberg.com.
  12. "Team". ocean biomedical.
  13. SEC. "Ocean Biomedical, Inc. IPO Investment Prospectus S-1". SEC.report. Retrieved July 13, 2021.
  14. "Preclinical biotech Ocean Biomedical files for a $100 million IPO". Renaissance Capital.
  15. Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Takeshita, Masafumi; Suetsugu, Takayuki; Kirita, Keisuke; Ebi, Noriyuki; Hataji, Osamu; Miura, Satoru; Chibana, Kenji; Okamoto, Isamu; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji (May 1, 2020). "A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)". BMC Cancer. 20 (1): 370. doi:10.1186/s12885-020-06874-6. PMC 7195707. PMID 32357848.
  16. "science". ocean biomedical.
  17. "coronavirus: US based company headed by NRI aims for Covid-19 vaccine – Times of India". The Times of India.
  18. "Groundbreaking malaria vaccine discovery". April 22, 2020.
  19. "Punjab NRI's company to try its new malaria vaccine on Covid-19 patients | Chandigarh News – Times of India". The Times of India.
  20. "Immune children aid malaria vaccine hunt". BBC News. May 22, 2014.
  21. Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Jolly, Grant; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; Conteh, Solomon; McDonald, Emily A.; Absalon, Sabrina; Holte, Sarah E.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D. (May 23, 2014). "Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection". Science. 344 (6186): 871–877. Bibcode:2014Sci...344..871R. doi:10.1126/science.1254417. PMC 4184151. PMID 24855263.
  22. "New Malaria Vaccine Shows Promise in Mice". www.science.org.
  23. "partnerships". ocean biomedical.
  24. "Brown Alpert Medical School Malaria Expert Kurtis on Gearing Up for Phase One Vaccine Trials LIVE". GoLocalProv.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.